Xuanzhang Huang

China Medical University First Hospital

H指数:30

被引数:2,447

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypoxia-driven remodeling of SELENOP+ macrophages shapes T cell dynamics and promotes ovarian cancer metastasis

乏氧驱动的SELENOP+巨噬细胞重塑塑造T细胞动态并促进卵巢癌转移

Nature Communications

IF15.7

2026-01-120

OAAI

Editorial: The crosstalk between emerging cell death and immune microenvironment remodeling in cancer progression and treatment

编辑述评：新兴细胞死亡与免疫微环境重塑在肿瘤进展和治疗中的串扰

Frontiers in Immunology

IF5.9

2025-10-160

OAAI

Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116+ pericytes in cancer metastasis

单细胞多组学和空间分析食管鳞状细胞癌揭示了GPR116+周细胞在癌症转移中的免疫抑制作用

Nature Genetics

IF29

2025-10-100

PRE

LIMK1 as a Novel Kinase of β-Catenin Promotes Esophageal Cancer Metastasis by Cooperating With CDK5

LIMK1作为β-Catenin的新型激酶，通过与CDK5协同作用促进食管癌转移

Advanced Science

IF14.1

2025-06-060

OAAI

Advances and Prospects in Liquid Biopsy Techniques for Malignant Tumor Diagnosis and Surveillance

SMALL

IF12.1

2024-07-311

Metaplastic regeneration in the mouse stomach requires a reactive oxygen species pathway

DEVELOPMENTAL CELL

IF8.7

2024-05-012

PRE

Construction of machine learning models based on transrectal ultrasound combined with contrast-enhanced ultrasound to predict preoperative regional lymph node metastasis of rectal cancer

HELIYON

IF3.6

2024-02-011

OAAI

Gastric intestinal metaplasia: progress and remaining challenges

胃肠上皮化生: 进展和仍然存在的挑战

JOURNAL OF GASTROENTEROLOGY

IF5.5

2024-01-194

PRE

A multicenter, retrospective, real-world study of inetetamab combined with pyrotinib and vinorelbine as treatment for HER2-positive metastatic breast cancer

inetetamab联合pyrotinib和长春瑞滨治疗HER2-positive转移性乳腺癌的多中心，回顾性，真实世界研究

ANNALS OF ONCOLOGY

IF65.4

2023-11-011

PRE

Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis

NATURE COMMUNICATIONS

IF15.7

2023-02-1438

OAAI

Elevated MMP10/13 mediated barrier disruption and NF-κB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice

CANCER LETTERS

IF10.1

2022-03-0115

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

BMC CANCER

IF3.4

2021-11-1327

OAAI

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer

BMC CANCER

IF3.4

2021-07-0814

OAAI

tRFTars: predicting the targets of tRNA-derived fragments

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2021-02-2522

OAAI

The Clinical Significance and Mechanisms of REG4 in Human Cancers

REG4在人类肿瘤中的临床意义及作用机制

FRONTIERS IN ONCOLOGY

IF3.3

2021-01-0814

OAAI

Conversion Surgery for Stage IV Gastric Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2019-11-0726

OAAI

Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients

癌症患者的抗生素使用和免疫检查点抑制剂的疗效: 对2740名癌症患者的汇总分析

ONCOIMMUNOLOGY

IF6.3

2019-09-2399

OAAI

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

肿瘤标志物在食管鳞癌预后及化疗疗效预测中的临床应用

BMC CANCER

IF3.4

2019-05-3151

OAAI

Effect of bisphosphonates on overall survival in subgroups of patients with prostate cancer

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2019-04-087

PREAI

Clinicopathological features and endocrine therapy mode of ER low expression (1%-9%) breast cancer patients in China

CANCER RESEARCH

IF16.6

2019-02-150

PRE

Xuanzhang Huang

个人简介

教育背景

工作经历

荣誉奖项

研究方向